Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156075 | SCV000205788 | likely benign | not specified | 2013-11-12 | criteria provided, single submitter | clinical testing | Ser81Ser in exon 1 of DES: This variant is not expected to have clinical signifi cance because it does not alter an amino acid residue and is not located within the splice consensus sequence. ** Ser81Ser in exon 1 of DES (allele frequency = n/a) |
Eurofins Ntd Llc |
RCV000156075 | SCV000332849 | likely benign | not specified | 2016-08-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000471679 | SCV000562346 | likely benign | Desmin-related myofibrillar myopathy | 2025-01-17 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000156075 | SCV000613088 | likely benign | not specified | 2017-06-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697118 | SCV000716761 | likely benign | not provided | 2021-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620327 | SCV000737004 | benign | Cardiovascular phenotype | 2016-12-14 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003486705 | SCV004240481 | benign | Cardiomyopathy | 2023-01-31 | criteria provided, single submitter | clinical testing |